US study reveals age-related skin changes could contribute to melanoma metastases
Around 200,000 people in the US are expected to be diagnosed with the skin cancer this year
Read More
Tag: skin cancer
Researchers develop terahertz biosensor to detect skin cancer for early diagnosis
Results from the study could also be used for other forms of cancer and diseases
Read More
Immune cell helps predict skin cancer patients’ responses to immunotherapies
Vd1-gd T cells were effective in predicting positive responses to ICI therapy
Read More
Centre for Genomic Regulation and Almirall join forces on skin cancer treatments
The collaboration aims to develop novel preclinical models with a view to identifying new treatments
Read More
Keytruda gains expanded US approval in skin cancer
Checkpoint inhibitor has been approved to treat locally advanced cutaneous squamous cell carcinoma
Read More
BMS’ Opdivo plus LAG-3 antibody relatlimab show promise in melanoma
RELATIVITY-047 trial met primary endpoint of progression-free survival
Read More
Skin cancer deaths rocket 70% since the 1970s
Melanoma incidence rates have more than doubled in the UK
Read More
UK report finds low awareness of non-melanoma skin cancer
More than 152,000 new cases of NMSC are diagnosed every year – more than breast, prostate and lung cancers combined
Read More
MSD’s Keytruda bags approval for new skin cancer indication
In trials Keytruda showed ‘meaningful efficacy’ with an objective response rate of 34%
Read More
EMA confirms skin cancer risk with LEO’s Picato
The agency concluded that the risks of the medicine outweigh its benefits
Read More
LEO issues Picato recall
Last September, the EMA’s Pharmacovigilance Risk Assessment Committee announced a review of data on skin cancer in patients using the drug.
Read More
Skin cancer rates rocket 45% in 10 years
Rates have increased by more than a third (35%) for women and by almost three-fifths (55%) for men.
Read More
- King’s Doctoral Training Centre to investigate MS symptom management
- Agenda announced for FlyPharma Vienna 2024
- Therapy reprogrammes immune cells to shrink prostate and bladder cancers
- Researchers combine herpes virus with cancer vaccine to treat brain cancer in children
- UK MRC and AstraZeneca partner for translational clinical research
